These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30997961)

  • 1. Oral Ketamine for Depression, 2: Practical Considerations.
    Andrade C
    J Clin Psychiatry; 2019 Apr; 80(2):. PubMed ID: 30997961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
    Andrade C
    J Clin Psychiatry; 2017 Jul; 78(7):e852-e857. PubMed ID: 28749092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Ketamine for Depression, 1: Pharmacologic Considerations and Clinical Evidence.
    Andrade C
    J Clin Psychiatry; 2019 Apr; 80(2):. PubMed ID: 30946543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety.
    Szarmach J; Cubała WJ; Włodarczyk A; Wiglusz MS
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):585-590. PubMed ID: 31488795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
    Katalinic N; Lai R; Somogyi A; Mitchell PB; Glue P; Loo CK
    Aust N Z J Psychiatry; 2013 Aug; 47(8):710-27. PubMed ID: 23661785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial.
    Jafarinia M; Afarideh M; Tafakhori A; Arbabi M; Ghajar A; Noorbala AA; Saravi MA; Agah E; Akhondzadeh S
    J Affect Disord; 2016 Nov; 204():1-8. PubMed ID: 27317968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ketamine for the treatment of pain and treatment-resistant depression†.
    Schoevers RA; Chaves TV; Balukova SM; aan het Rot M; Kortekaas R
    Br J Psychiatry; 2016 Feb; 208(2):108-13. PubMed ID: 26834167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine and depression: a narrative review.
    Corriger A; Pickering G
    Drug Des Devel Ther; 2019; 13():3051-3067. PubMed ID: 31695324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Subcutaneous Ketamine Dose Followed by Oral Ketamine for Depression Symptoms in Hospice Patients: A Case Series.
    Latuga NM; Luczkiewicz DL; Grant PC; Levy K; Hansen E; Kerr CW
    J Pain Palliat Care Pharmacother; 2021 Jun; 35(2):106-112. PubMed ID: 33847212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Singh JB; Fedgchin M; Cooper K; Lim P; Shelton RC; Thase ME; Winokur A; Van Nueten L; Manji H; Drevets WC
    JAMA Psychiatry; 2018 Feb; 75(2):139-148. PubMed ID: 29282469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action.
    Andrade C
    J Clin Psychiatry; 2017 Apr; 78(4):e415-e419. PubMed ID: 28448702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esketamine for treatment resistant depression.
    Jauhar S; Morrison P
    BMJ; 2019 Sep; 366():l5572. PubMed ID: 31548292
    [No Abstract]   [Full Text] [Related]  

  • 14. Side-effects associated with ketamine use in depression: a systematic review.
    Short B; Fong J; Galvez V; Shelker W; Loo CK
    Lancet Psychiatry; 2018 Jan; 5(1):65-78. PubMed ID: 28757132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions.
    Riva-Posse P; Reiff CM; Edwards JA; Job GP; Galendez GC; Garlow SJ; Saah TC; Dunlop BW; McDonald WM
    J Affect Disord; 2018 Aug; 236():291-297. PubMed ID: 29525051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant Effects.
    Feifel D
    Drug Dev Res; 2016 Dec; 77(8):489-494. PubMed ID: 27888525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ketamine administration in case of severe, therapy resistant depressed patient, case report].
    Morvai S; Nagy AI; Bálint-Szöllősi A; Móré EC; Berecz R; Frecska E
    Ideggyogy Sz; 2016 Nov; 69(11-12):421-425. PubMed ID: 29733561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study.
    Hartberg J; Garrett-Walcott S; De Gioannis A
    Psychopharmacology (Berl); 2018 Feb; 235(2):393-398. PubMed ID: 29151192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine helps a third of patients with treatment resistant depression, finds small UK study.
    Torjesen I
    BMJ; 2014 Apr; 348():g2576. PubMed ID: 24699320
    [No Abstract]   [Full Text] [Related]  

  • 20. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression.
    Loo CK; Gálvez V; O'Keefe E; Mitchell PB; Hadzi-Pavlovic D; Leyden J; Harper S; Somogyi AA; Lai R; Weickert CS; Glue P
    Acta Psychiatr Scand; 2016 Jul; 134(1):48-56. PubMed ID: 27028832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.